Growth-Health and Development in Children Exposed to Drugs During Pregnancy
1 other identifier
observational
170
1 country
2
Brief Summary
"Children exposed to alcohol or drugs during pregnancy: Growth, health and development" Background Children exposed to drugs during pregnancy are at risk of developmental disorders. The scope and size of this problem is poorly known in Norway. Alcohol has a known teratogenic effect on the fetus. How other drugs affect the fetus, is associated with more uncertainty. Withdrawal in the neonatal period has been perceived as the main problem. There is less knowledge about long-term outcome of exposure to drugs during pregnancy. Aim The aim of the study is to investigate the physical and mental health of children exposed to drugs during pregnancy. Identify the children's need for measures in the home and school, and how many of the children who are taken care of in fostercare. A sample of the children will be offered radiological examination of the brain (f-MRI). The purpose is to study the relationship between exposure to drugs, child development, environment and organic brain dysfunction. Design The project is a quantitative study. The relationship between exposure to drugs and development will be measured by questionnaires, clinical examination, neuropsychological tests and radiological examination (f-MRI). Children aged 2-15years who were referred, examined or treated for drug related problems at the Department of Pediatrics, Haukeland University Hospital will be invited to participate in the study. Information retrieval and examination of the children are expected to be completed during 2011. Data analysis and further processing of data are expected to be completed during 2013.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2011
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFirst Posted
Study publicly available on registry
July 25, 2016
CompletedAugust 17, 2016
August 1, 2016
1.8 years
April 1, 2011
August 16, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mental Health Disorder
Questionaire regarding mental health: Strength and Difficulties Questionnaires
2012
Other Outcomes (1)
Social status
2012
Study Arms (2)
Control
Children born at term and not exposed to drugs during pregnancy
Case
Case = Children exposed to drugs during pregnancy
Eligibility Criteria
Children exposed to drugs during pregnancy are followed up at school age regarding mental disorders and status of their care situation. Approximately 130 children are invited to the study.
You may qualify if:
- Foetal exposure of drugs during pregnancy.
You may not qualify if:
- Non exposed children
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Haukeland universitet sykehus
Bergen, 5021, Norway
Haukelans universitetssykehus
Bergen, 5021, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Irene B Elgen, Professor
Department of Child and Adolscent Psychiatry, Haukeland University Hospital, N-5018 Bergen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2011
First Posted
July 25, 2016
Study Start
February 1, 2011
Primary Completion
December 1, 2012
Study Completion
May 1, 2013
Last Updated
August 17, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share